Novel heterozygous FOXN1 mutation identified following newborn screening for severe combined immunodeficiency is associated with improving immune parameters
Abstract
Background: Forkhead-box protein N1 (FOXN1) plays a critical role in the proper development and function of thymic epithelial cells, required for T cell ontogeny. Homozygous variants in the FOXN1 gene, encoding FOXN1, cause severe combined immunodeficiency (SCID), whereas heterozygous mutations are associated with variable presentations and over time, improving T cell function.
Aim: To highlight the importance of broader genetic investigations to attain a definitive molecular diagnosis following abnormal newborn screening for SCID.
Methods: Case report of a patient with immunodeficiency due to a novel de novo FOXN1 mutation.
Results: The patient was identified following abnormal newborn screening for SCID in which T cell receptor excision circles were absent/very low. Initial immune investigations revealed severe T cell lymphopenia and poor lymphocyte function and she was diagnosed with T-B+NK+SCID. During work-up for hematopoietic stem cell transplantation, extensive genetic investigations identified a novel heterozygous mutation in FOXN1. A more conservative management approach was taken, and over the following months, the patient’s immune parameters improved.
Conclusion: Newborn screening for SCID has facilitated the detection of SCID, as well as other T cell immunodeficiencies, before infectious complications and organ damage occur. Heterozygous mutations in FOXN1 are associated with more variable presentations including improving immune indices with age. Here, results of genetic investigations were essential for informing the management of this case.
Statement of Novelty: We report a novel heterozygous mutation in FOXN1, presenting initially as T-B+NK+ SCID with gradual improvement of immune parameters over time.
Formats available
You can view the full content in the following formats:
REFERENCES
Acuna-Hidalgo R., Veltman J.A., and Hoischen A. 2016. New insights into the generation and role of de novo mutations in health and disease. Genome Biol. 17(1): 241.
Amatuni G.S., Currier R.J., Church J.A., Bishop T., Grimbacher E., Nguyen A.A.-C., Agarwal-Hashmi R., Aznar C.P., Butte M.J., Cowan M.J., Dorsey M.J., Dvorak C.C., Kapoor N., Kohn D.B., Markert M.L., Moore T.B., Naides S.J., Sciortino S., Feuchtbaum L., and Puck J.M. 2019. Newborn screening for severe combined immunodeficiency and T-cell lymphopenia in California, 2010–2017. Pediatrics, 143(2): e20182300.
Amorosi S., D’Armiento M., Calcagno G., Russo I., Adriani M., Christiano A.M., Weiner L., Brissette J.L., and Pignata C. 2008. Foxn1 homozygous mutation associated with anencephaly and severe neural tube defect in human athymic nude/SCID fetus. Clinical Genetics, 73(4): 380–384.
Ara T., Itoi M., Kawabata K., Egawa T., Tokoyoda K., Sugiyama T., Fujii N., Amagai T., and Nagasawa T. 2003. A role of CXC chemokine ligand 12/stromal cell-derived factor-1/pre-B cell growth stimulating factor and its receptor CXCR4 in fetal and adult T cell development in vivo. J. Immunol. 170(9): 4649–4655.
Biggs C.M., Haddad E., Issekutz T.B., Roifman C.M., and Turvey S.E. 2017. Newborn screening for severe combined immunodeficiency: A Primer for clinicians. Can. Med. Assoc. J. 189(50).
Bosticardo M., Yamazaki Y., Cowan J., Giardino G., Corsino C., Scalia G., Prencipe R., Ruffner M., Hill D.A., Sakovich I., Yemialyanava I., Tam J.S., Padem N., Elder M.E., Sleasman J.W., Perez E., Niebur H., Seroogy C.M., Sharapova S., and Notarangelo L.D. 2019. Heterozygous FOXN1 variants cause low trecs and severe T cell lymphopenia, revealing a crucial role of Foxn1 in supporting early thymopoiesis. Am. J. Hum. Genet. 105(3): 549–561.
Chen L., Xiao S., and Manley N.R. 2009. FOXN1 is required to maintain the postnatal thymic microenvironment in a dosage-sensitive manner. Blood, 113(3): 567–574.
Chou J., Massaad M.J., Wakim R.H., Bainter W., Dbaibo G., and Geha R.S. 2014. A novel mutation in FOXN1 resulting in SCID: A case report and literature review. Clinical Immunol. 155(1): 30–32.
Corbeaux T., Hess I., Swann J.B., Kanzler B., Haas-Assenbaum A., and Boehm T. 2010. Thymopoiesis in mice depends on a foxn1-positive thymic epithelial cell lineage. Proc. National Academy Sci. 107(38): 16613–16618.
Cowan J.E., Takahama Y., Bhandoola A., and Ohigashi I. 2020. Postnatal involution and counter-involution of the thymus. Front Immunol. 11: 897.
Currier R. and Puck J.M. 2021. SCID newborn screening: What we’ve learned. J. Allergy Clinical Immunol. 147(2): 417–426.
Du Q., Huynh L.K., Coskun F., Molina E., King M.A., Raj P., Khan S., Dozmorov I., Seroogy C.M., Wysocki C.A., Padron G.T., Yates T.R., Markert M.L., de la Morena M.T., and van Oers N.S.C. 2019. FOXN1 compound heterozygous mutations cause selective thymic hypoplasia in humans. J. Clin. Invest. 129(11): 4724–4738.
Frank J., Pignata C., Panteleyev A.A., Prowse D.M., Baden H., Weiner L., Gaetaniello L., Ahmad W., Pozzi N., Cserhalmi-Friedman P.B., Aita V.M., Uyttendaele H., Gordon D., Ott J., Brissette J.L., and Christiano A.M. 1999. Exposing the human nude phenotype. Nature, 398(6727): 473–474.
Koch U., Fiorini E., Benedito R., Besseyrias V., Schuster-Gossler K., Pierres M., Manley N.R., Duarte A., MacDonald H.R., and Radtke F. 2008. Delta-like 4 is the essential, nonredundant ligand for Notch1 during thymic T cell lineage commitment. J. Exp. Med. 205(11): 2515–2523.
Kwan A., Abraham R.S., Currier R., Brower A., Andruszewski K., Abbott J.K., Baker M., Ballow M., Bartoshesky L.E., Bonilla F.A., Brokopp C., Brooks E., Caggana M., Celestin J., Church J.A., Comeau A.M., Connelly J.A., Cowan M.J., Cunningham-Rundles C., and Puck J.M. 2014. Newborn screening for severe combined immunodeficiency in 11 screening programs in the United States. JAMA, 312(7): 729.
Liu H. and Leung B.P. 2006. CD4+CD25+ regulatory T cells in health and disease. Clin. Exp. Pharmacol. Physiol. 33(5–6): 519–524.
Mandola A.B., Reid B., Sirror R., Brager R., Dent P., Chakroborty P., Bulman D.E., and Roifman C.M. 2019. Ataxia telangiectasia diagnosed on newborn screening–case cohort of 5 Years’ experience. Front Immunol. 10: 2940.
Nehls M., Pfeifer D., Schorpp M., Hedrich H., and Boehm T. 1994. New member of the winged-helix protein family disrupted in mouse and rat nude mutations. Nature, 372(6501): 103–107.
Newman J.A., Aitkenhead H., Gavard A.E., Rota I.A., Handel A.E., Hollander G.A., and Gileadi O. 2020. The crystal structure of human forkhead box N1 in complex with DNA reveals the structural basis for forkhead box family specificity. J. Biol. Chem. 295(10): 2948–2958.
Palmer D.B., Viney J.L., Ritter M.A., Hayday A.C., and Owen M.J. 1993. Expression of the αβ T-cell receptor is necessary for the generation of the thymic medulla. Dev. Immunol. 3(3): 175–179.
Pignata C., Fiore M., Guzzetta V., Castaldo A., Sebastio G., Porta F., and Guarino A. 1996. Congenital alopecia and nail dystrophy associated with severe functional T-cell immunodeficiency in two sibs. Am. J. Med. Genet. 65(2): 167–170.
Radha Rama Devi A., Panday N.N., and Naushad S.M. 2017. Foxn1 Italian founder mutation in Indian family: Implications in prenatal diagnosis. Gene. 627: 222–225.
Roberts N.A., Desanti G.E., Withers D.R., Scott H.R., Jenkinson W.E., Lane P.J., Jenkinson E.J., and Anderson G. 2009. Absence of thymus crosstalk in the fetus does not preclude hematopoietic induction of a functional thymus in the adult. European J. Immunol. 39(9): 2395–2402.
Rode I., Martins V.C., Küblbeck G., Maltry N., Tessmer C., and Rodewald H.-R. 2015. FOXN1 protein expression in the developing, aging, and regenerating thymus. J. Immunol. 195(12): 5678–5687.
Romano R., Palamaro L., Fusco A., Giardino G., Gallo V., Del Vecchio L., and Pignata C. 2013. Foxn1: A master regulator gene of thymic epithelial development program. Front Immunol. 4: 187.
Rota I.A. and Dhalla F. 2017. FOXN1 deficient nude severe combined immunodeficiency. Orphanet J. Rare Dis. 12(1).
Rota I.A., Handel A.E., Maio S., Klein F., Dhalla F., Deadman M.E., Cheuk S., Newman J.A., Michaels Y.S., Zuklys S., Prevot N., Hublitz P., Charles P.D., Gkazi A.S., Adamopoulou E., Qasim W., Davies E.G., Hanson I., Pagnamenta A.T., and Holländer G.A. 2021. Foxn1 forms higher-order nuclear condensates displaced by mutations causing immunodeficiency. Sci. Adv. 7(49): eabj9247.
Ruan L., Zhang Z., Mu L., Burnley P., Wang L., Coder B., Zhuge Q., and Su D.-M. 2014. Biological significance of FoxN1 gain-of-function mutations during T and B lymphopoiesis in juvenile mice. Cell Death Dis. 5(10): e1457.
Scott O., Garkaby J., Willett-Pachul J., Mandola A.B., and Pasternak Y. 2021. A novel splice site variant in FOXN1 in a patient with abnormal newborn screening for severe combined immunodeficiency and congenital lymphopenia. LymphoSign J. 8(1): 1–4.
Shah S.S., Lai S.Y., Ruchelli E., Kazahaya K., and Mahboubi S. 2001. Retropharyngeal aberrant thymus. Pediatrics, 108(5): E94.
Vaidya H.J., Briones Leon A., and Blackburn C.C. 2016. Foxn1 in thymus organogenesis and development. Europ. J. Immunol. 46(8): 1826–1837.
van Ewijk W., Shores E.W., and Singer A. 1994. Crosstalk in the mouse thymus. Immunol. Today, 15(5): 214–217.
Zook E.C., Zhang S., Gerstein R.M., Witte P.L., and Le P.T. 2013. Enhancing T lineage production in aged mice: A novel function of Foxn1 in the bone marrow niche. J. Immunol. 191(11): 5583–5593.
Žuklys S., Handel A., Zhanybekova S., Govani F., Keller M., Maio S., Mayer C.E., Teh H.Y., Hafen K., Gallone G., Barthlott T., Ponting C.P., and Holländer G.A. 2016. Foxn1 regulates key target genes essential for T cell development in postnatal thymic epithelial cells. Nat. Immunol. 17(10): 1206–1215.
Information & Authors
Information
Published In
LymphoSign Journal
Volume 9 • Number 2 • June 2022
Pages: 45 - 51
History
Received: 24 May 2022
Accepted: 30 May 2022
Accepted manuscript online: 30 May 2022
Copyright
© 2022.
Authors
Metrics & Citations
Metrics
Other Metrics
Citations
Cite As
Laura EdithAbrego Fuentes, JennyGarkaby, JessicaWillett Pachul, AbbyWatts-Dickens, MeghanFraser, Vy H.D.Kim, and Chaim M.Roifman. 2022. Novel heterozygous FOXN1 mutation identified following newborn screening for severe combined immunodeficiency is associated with improving immune parameters. LymphoSign Journal.
9(2): 45-51. https://doi.org/10.14785/lymphosign-2022-0007
Export Citations
If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.
There are no citations for this item
View Options
Get Access
Login options
Check if you access through your login credentials or your institution to get full access on this article.
